Douglas A. Greene

7.5k citations

82 papers · 6.1k indexed · 1 hit paper · h-index 44

Physiology top 0.5%
Neurology top 0.5%
Endocrinology, Diabetes and Metabolism top 0.5%
Molecular Biology top 10%
Cell Biology top 1%

Co-authors: S. A. Lattimer Anders A. F. Sima Eva L. Feldman Jeffrey S. Flier Lisa H. Underhill Irina G. Obrosova Albert I. Winegrad Martin Stevens
Topics: Pain Mechanisms and Treatments (47 papers)Botulinum Toxin and Related Neurological Disorders (25 papers)Aldose Reductase and Taurine (14 papers)
Cited by: Physiology Neurology Clinical Biochemistry
Journals: New England Journal of Medicine Journal of the American College of Cardiology The Journal of Clinical Endocrinology & Metabolism
Partner nations: United States Canada United Kingdom

In The Last Decade

Douglas A. Greene

82 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic Complications

1987 758 citations Douglas A. Greene, S. A. Lattimer et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Douglas A. Greene

Since Specialization

Citations

This map shows the geographic impact of Douglas A. Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas A. Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas A. Greene more than expected).

Fields of papers citing papers by Douglas A. Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas A. Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas A. Greene. The network helps show where Douglas A. Greene may publish in the future.

Co-authorship network of co-authors of Douglas A. Greene

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas A. Greene. A scholar is included among the top collaborators of Douglas A. Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas A. Greene. Douglas A. Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion 2006 ·Diabetes Care ·Catherine L. Martin,James W. Albers,William H. Herman,Patricia A. Cleary,Barbara H. Waberski,Douglas A. Greene,Martin Stevens,Eva L. Feldman	246
2	The Lichens and Bryophytes of the Boston Harbor Islands 2005 ·Northeastern Naturalist ·(unknown),(unknown),Douglas A. Greene,(unknown),(unknown)	12
3	Establishment, Maintenance, and Transfection of In Vitro Cultures of Human Retinal Pigment Epithelium 2004 ·Humana Press eBooks ·Martin J. Stevens,Dennis Larkin,Eva L. Feldman,Monte A. Del Monte,Douglas A. Greene	5
4	Establishment and Maintenance of In Vitro Cultures of Human Retinal Pigment Epithelium 2003 ·Humana Press eBooks ·Eva L. Feldman,Monte A. Del Monte,Martin J. Stevens,Douglas A. Greene	1
5	Peroxisome proliferator-activated receptor (PPAR)γ agonists for diabetes 2001 ·Advances in protein chemistry ·David E. Moller,Douglas A. Greene	31
6	Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy 2000 ·Journal of Diabetes and its Complications ·Yadollah Harati,Clifton L. Gooch,Michael Swenson,Steven V. Edelman,Douglas A. Greene,Philip Raskin,Peter D. Donofrio,David R. Cornblath,William H. Olson,Marc Kamin	136
7	Acute effects of adrenergic-mediated ischemia on nerve conduction in subjects with type 2 diabetes 1999 ·Metabolism ·Robert Hogikyan,John J. Wald,Eva L. Feldman,Douglas A. Greene,Jeffrey B. Halter,Mark A. Supiano	9
8	2-Chloroadenosine reverses hyperglycemia-induced inhibition of phosphoinositide synthesis in cultured human retinal pigment epithelial cells and prevents reduced nerve conduction velocity in diabetic rats 1999 ·Metabolism ·Koichi Kato,Thommey P. Thomas,M. J. Stevens,Douglas A. Greene,(unknown)	7
9	Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy 1999 ·European Journal of Pharmacology ·Douglas A. Greene,Martin J. Stevens,Irina G. Obrosova,Eva L. Feldman	189
10	Specific Impairment of Endothelium-Dependent Vasodilation in Subjects with Type 2 Diabetes Independent of Obesity¹ 1998 ·The Journal of Clinical Endocrinology & Metabolism ·Robert Hogikyan,Andrzej T. Gałecki,Bertram Pitt,Jeffrey B. Halter,Douglas A. Greene,Mark A. Supiano	117
11	A Multicenter Study on the Prevalence of Diabetic Neuropathy in Italy 1997 ·Diabetes Care ·Domenico Fedele,Gıancarlo Comı,C Coscelli,Domenico Cucinotta,Eva L. Feldman,Giovanni Ghirlanda,Douglas A. Greene,P Negrin,Fausto Santeusanio	121
12	Glucose transporters in rat peripheral nerve: Paranodal expression of GLUT1 and GLUT3 1996 ·Metabolism ·Paolo Magnani,Paul Cherian,Gwyn W. Gould,Douglas A. Greene,(unknown),Frank C. Brosius	59
13	Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial 1996 ·Neurology ·James W. Albers,Morton B. Brown,Anders A. F. Sima,Douglas A. Greene	74
14	Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT) 1996 ·Muscle & Nerve ·James W. Albers,Morton B. Brown,Anders A. F. Sima,Douglas A. Greene	69
15	Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy 1993 ·Journal of Diabetes and its Complications ·Anders A. F. Sima,Douglas A. Greene,Morton B. Brown,Thomas C. Hohman,David Hicks,(unknown),Wieslaw Bochenek,(unknown),Boas Gonen	57
16	Receptor‐Coupled Phosphoinositide Hydrolysis in Human Retinal Pigment Epithelium 1991 ·Journal of Neurochemistry ·Eva L. Feldman,Ann Randolph,(unknown),Monte A. Del Monte,Douglas A. Greene	31
17	Diabetic and hypoglycemic neuropathy — a comparison in the BB rat 1989 ·Diabetes Research and Clinical Practice ·Anders A. F. Sima,Wei‐xian Zhang,Douglas A. Greene	26
18	Regeneration and Repair of Myelinated Fibers in Sural-Nerve Biopsy Specimens from Patients with Diabetic Neuropathy Treated with Sorbinil 1988 ·New England Journal of Medicine ·Anders A. F. Sima,Vera Bril,Virgil Nathaniel,(unknown),Morton B. Brown,S. A. Lattimer,Douglas A. Greene	249
19	Pathogenesis and prevention of diabetic neuropathy 1988 ·Diabetes/Metabolism Reviews ·Douglas A. Greene,S. A. Lattimer,Anders A. F. Sima	72
20	The pathogenesis and prevention of diabetic neuropathy and nephropathy 1988 ·Metabolism ·Douglas A. Greene	31

About Douglas A. Greene

Douglas A. Greene is a scholar working on Physiology, Neurology and Cell Biology, having authored 82 papers that have together received 6.1k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (47 papers), Botulinum Toxin and Related Neurological Disorders (25 papers) and Aldose Reductase and Taurine (14 papers). The work is most often cited by research in Physiology (3.0k citations), Neurology (1.6k citations) and Clinical Biochemistry (673 citations). Douglas A. Greene has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include S. A. Lattimer, Anders A. F. Sima, Eva L. Feldman, Jeffrey S. Flier, Lisa H. Underhill, Irina G. Obrosova, Albert I. Winegrad, Martin Stevens, Martin J. Stevens and Lamia Fathallah. Their work appears in journals such as New England Journal of Medicine, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact